9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
QuantumLeap Healthcare Collaborative
Emory University
USWM, LLC (dba US WorldMeds)
Centre Leon Berard
UNICANCER
Gustave Roussy, Cancer Campus, Grand Paris
Bayer
Institut Bergonié
Pfizer
University of California, San Diego
EpicentRx, Inc.
Novartis
ImmunityBio, Inc.
University of Virginia
Seattle Children's Hospital
Sunnybrook Health Sciences Centre
National Institutes of Health Clinical Center (CC)
Novartis
Hoffmann-La Roche
GlaxoSmithKline
Grupo Espanol de Investigacion en Sarcomas
University of Manchester
DNAtrix, Inc.
Oncovir, Inc.
Children's Hospital of Philadelphia
Celldex Therapeutics
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
SCRI Development Innovations, LLC
InSightec
Memorial Sloan Kettering Cancer Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
National Cancer Institute (NCI)
University Hospital Muenster
AstraZeneca
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)